SCHEDULE 3Amendments consequential on the establishment of the National Health Service Commissioning Board and clinical commissioning groups
The Medicines for Human Use (Clinical Trials) Regulations 20048
1
The Medicines for Human Use (Clinical Trials) Regulations 200422 are amended as follows.
2
In regulation 2(1) (interpretation), in the definition of “health service body”—
a
in paragraph (b), after “Primary Care Trust” insert “, clinical commissioning group”; and
b
after paragraph (b) insert—
ba
the National Health Service Commissioning Board,
3
In Schedule 2 (additional provisions relating to Ethics Committees)—
a
in paragraph 3(5)(b)(iii), at the end of paragraph (bb) insert—
; or
cc
the governing body of a clinical commissioning group
b
in paragraph 6(6)(a)(ii), after “health service body” insert “or the governing body of a clinical commissioning group”.